How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial.

Author: CannonChristoper P, ConnorsLaurine G, CurtisSean P, GoldkindLawrence, LaineLoren, YanqiongZhang

Paper Details 
Original Abstract of the Article :
OBJECTIVES: Few data are available from prospective trials to define the hepatotoxicity of diclofenac, the most widely prescribed non-steroidal anti-inflammatory drug (NSAID) in the world. We determined the rate of laboratory and clinical adverse hepatic effects in a large double-blind trial of dicl...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1038/ajg.2008.149

データ提供:米国国立医学図書館(NLM)

Diclofenac and Liver Health: A Desert Oasis of Caution

Diclofenac, a common painkiller, is like a reliable camel in the desert of pain relief. This study, conducted like a meticulous desert expedition, investigated the potential liver effects of diclofenac in a large group of arthritis patients. They recruited over 17,000 patients with arthritis and randomly assigned them to receive diclofenac or etoricoxib, another pain reliever. They closely monitored their liver function over an average of 18 months. The results were as clear as a desert mirage: diclofenac was commonly associated with elevated liver enzymes, particularly during the first 4-6 months of treatment. While severe liver events requiring hospitalization were rare, they did occur. This study, like a beacon in the desert, highlights the importance of careful monitoring for potential liver complications when using diclofenac.

Diclofenac and Liver Enzymes: A Desert Oasis with a Warning Sign

This study, as vast as the desert itself, demonstrates that diclofenac can cause elevated liver enzymes in some patients. While this doesn't necessarily mean that everyone taking diclofenac will experience liver problems, it emphasizes the need for regular monitoring of liver function, especially during the early stages of treatment. The findings are as clear as a desert sky at sunset, offering valuable guidance for clinicians and patients alike.

Diclofenac and Liver Health: Navigating the Desert Landscape

Diclofenac, a widely used pain reliever, can be a valuable tool for managing pain, but it's crucial to be aware of its potential impact on liver health. Regular monitoring of liver function and open communication with a healthcare professional are essential to ensure safe and effective treatment. This study, like a well-marked trail in the desert, provides valuable information for those seeking to manage their pain while minimizing potential risks.

Dr. Camel's Conclusion

Diclofenac, a common pain reliever, can be associated with elevated liver enzymes. While severe liver complications are rare, regular monitoring is essential to ensure safe and effective treatment. This study, as clear as a desert oasis after a long trek, serves as a reminder to be vigilant about potential liver issues when using diclofenac.
Date :
  1. Date Completed 2009-03-03
  2. Date Revised 2022-03-16
Further Info :

Pubmed ID

19174782

DOI: Digital Object Identifier

10.1038/ajg.2008.149

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.